Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 18, Issue 5, Pages 307-313
http://dx.doi.org/10.1155/2004/864292
Original Article

Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough

Ioannis S Elefsiniotis,1 Nikolaos Scarmeas,2 Irene Glynou,3 Konstantinos D Pantazis,1 Helen Kada,3 and Christos Mavrogiannis1

1Department of Hepatogastroenterology, University of Athens, ‘Helena Venizelou’ Hospital, Athens, Greece
2New York Presbyterian Hospital, Columbia University, New York, USA
3Department of Microbiology, ‘Helena Venizelou’ Hospital, Athens, Greece

Received 9 October 2003; Accepted 19 March 2004

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ioannis S Elefsiniotis, Nikolaos Scarmeas, Irene Glynou, Konstantinos D Pantazis, Helen Kada, and Christos Mavrogiannis, “Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough,” Canadian Journal of Gastroenterology, vol. 18, no. 5, pp. 307-313, 2004. https://doi.org/10.1155/2004/864292.